RT Journal
A1 Stephenson J
T1 DIabetes drug may be associated with increase in risk of bladder cancer
JF JAMA
JO JAMA
YR 2011
FD July 13
VO 306
IS 2
SP 143
OP 143
DO 10.1001/jama.2011.939
UL http://dx.doi.org/10.1001/jama.2011.939
AB 
The FDA is advising health care professionals to not use pioglitazone in patients with active bladder cancer and to prescribe the drug with caution for patients with a prior history of bladder cancer, weighing the benefits of blood glucose control “against the unknown risks for cancer recurrence” (http://tinyurl.com/3owghao).